Literature DB >> 12930805

Group I metabotropic glutamate receptors in the monkey striatum: subsynaptic association with glutamatergic and dopaminergic afferents.

Maryse Paquet1, Yoland Smith.   

Abstract

Group I metabotropic glutamate receptors (mGluRs) are involved in long-term synaptic plasticity and neuroprotection in the striatum, but the specific role(s) of mGluR1 and mGluR5 remain poorly understood. In this study, we used electron-microscopic immunocytochemistry to compare the pattern of subsynaptic and subcellular distribution of mGluR1a and mGluR5 in relation to putative glutamatergic and dopaminergic inputs to the monkey striatum. At the light-microscopic level, both group I mGluRs are expressed in the striatal neuropil. In addition, numerous perikarya of striatal output neurons are immunostained for mGluR5, but much less frequently for mGluR1a. At the electron-microscopic level, immunoreactivity for both receptor subtypes is primarily expressed postsynaptically in dendrites and spines, although presynaptic mGluR1a labeling of glutamatergic thalamostriatal boutons and, less frequently, dopaminergic and corticostriatal terminals is also seen. In contrast to mGluR1a, mGluR5 immunoreactivity is rarely encountered presynaptically. In postsynaptic elements, 40-70% of immunoreactivity for both receptor subtypes is expressed intracellularly, whereas 30-60% is apposed to the plasma membrane. More than 80% of the labeling apposed to the plasma membrane is extrasynaptic. The remaining 20% is located at the edges of putative glutamatergic synapses or in the active zone of symmetric synapses. In mGluR5-, but not mGluR1a-immunostained sections, approximately 70% of dopaminergic symmetric synapses are labeled perisynaptically. These data emphasize the differential pattern of subsynaptic localization of the two group I mGluRs and provide various presynaptic and postsynaptic sites whereby mGluR1 and mGluR5 could mediate different, but complementary, effects on glutamatergic and dopaminergic transmission in the primate striatum.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12930805      PMCID: PMC6740746     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  45 in total

Review 1.  Parkinson's disease therapeutics: new developments and challenges since the introduction of levodopa.

Authors:  Yoland Smith; Thomas Wichmann; Stewart A Factor; Mahlon R DeLong
Journal:  Neuropsychopharmacology       Date:  2011-09-28       Impact factor: 7.853

2.  Metabotropic glutamate receptor 1 splice variants mGluR1a and mGluR1b combine in mGluR1a/b dimers in vivo.

Authors:  Šárka Techlovská; Jayne Nicole Chambers; Michaela Dvořáková; Ronald S Petralia; Ya-Xian Wang; Alena Hájková; Alice Nová; Daniela Franková; Laurent Prezeau; Jaroslav Blahos
Journal:  Neuropharmacology       Date:  2014-08-23       Impact factor: 5.250

3.  P2Y1 receptor signaling is controlled by interaction with the PDZ scaffold NHERF-2.

Authors:  Sami R Fam; Maryse Paquet; Amanda M Castleberry; Heide Oller; C Justin Lee; Stephen F Traynelis; Yoland Smith; C Chris Yun; Randy A Hall
Journal:  Proc Natl Acad Sci U S A       Date:  2005-05-18       Impact factor: 11.205

Review 4.  Glutamate and GABA receptors and transporters in the basal ganglia: what does their subsynaptic localization reveal about their function?

Authors:  A Galvan; M Kuwajima; Y Smith
Journal:  Neuroscience       Date:  2006-10-23       Impact factor: 3.590

Review 5.  Neurotransmitter receptor heteromers and their integrative role in 'local modules': the striatal spine module.

Authors:  Sergi Ferré; Luigi F Agnati; Francisco Ciruela; Carme Lluis; Amina S Woods; Kjell Fuxe; Rafael Franco
Journal:  Brain Res Rev       Date:  2007-01-27

Review 6.  Metabotropic glutamate receptor ligands as potential therapeutics for addiction.

Authors:  M Foster Olive
Journal:  Curr Drug Abuse Rev       Date:  2009-01

7.  Metabotropic glutamate mGluR5 receptor blockade opposes abnormal involuntary movements and the increases in glutamic acid decarboxylase mRNA levels induced by l-DOPA in striatal neurons of 6-hydroxydopamine-lesioned rats.

Authors:  N Yamamoto; J-J Soghomonian
Journal:  Neuroscience       Date:  2009-08-04       Impact factor: 3.590

8.  The mGluR5 antagonist MPEP selectively inhibits the onset and maintenance of ethanol self-administration in C57BL/6J mice.

Authors:  Clyde W Hodge; Michael F Miles; Amanda C Sharko; Rebekah A Stevenson; Jennie R Hillmann; Veronique Lepoutre; Joyce Besheer; Jason P Schroeder
Journal:  Psychopharmacology (Berl)       Date:  2005-11-15       Impact factor: 4.530

Review 9.  Location-dependent signaling of the group 1 metabotropic glutamate receptor mGlu5.

Authors:  Yuh-Jiin I Jong; Ismail Sergin; Carolyn A Purgert; Karen L O'Malley
Journal:  Mol Pharmacol       Date:  2014-10-17       Impact factor: 4.436

10.  Dopamine-dependent corticostriatal synaptic filtering regulates sensorimotor behavior.

Authors:  M Y Wong; A Borgkvist; S J Choi; E V Mosharov; N S Bamford; D Sulzer
Journal:  Neuroscience       Date:  2015-01-28       Impact factor: 3.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.